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Letter to the EditorOn Mitochondria, Mutations,
and MethodologyWhether mutations in mitochondrial DNA
(mtDNA) are causal to, or merely corre-
lated with, aging is an area of intense
debate. Recently, this debate has intensi-
fied with the development of mitochon-
drial mutator mice. These mice carry an
error-prone copy of DNA polymerase
gamma (PolgA), the enzyme that repli-
cates the mitochondrial genome. We
found that heterozygous carriers of this
error-prone allele display a >100-fold
elevation in point mutation frequency
without manifesting features of premature
aging (Vermulst et al., 2007). These results
imply that mtDNA point mutations do not
limit the life span of normal mice.
Interestingly, homozygous carriers of
this allele do display extensive mitochon-
drial dysfunction and suffer from a prema-
ture aging-like syndrome (Trifunovic et al.,
2004). We found that this progeroid
syndrome correlated best with a large
increase in clonally expanded mtDNA
mutations (which could be either point
mutations or deletions) and a 10- to
90-fold increase in mtDNA deletions (Ver-
mulst et al., 2008). MtDNA deletions are
associated with a number of age-related
pathologies, including muscle wasting
and neuronal dysfunction. We reasoned
that, if the frequency of deletions in WT
animals is sufficient to perturb the func-
tion of aging neurons and muscle fibers,
a substantial increase in their frequency
should have a profound physiological
impact. For instance, a much milder
increase in mtDNA deletions results in late
onset mitochondrial disease in Twinkle-
deficient mice. Moreover, mtDNA dele-
tions are suppressed in certain long-lived
mice. A recent paper in Cell Metabolism
by Edgar et al. (2009) now challenges
the role of mtDNA deletions in the proge-
roid syndrome of mitochondrial mutator
mice.
In their study, Edgar et al. find that
protein supercomplexes in the electron
transport chain are unstable in the proge-
roid mice, and they argue that this type ofdysfunction could not have been gener-
ated by mtDNA deletions, which they
find to be too infrequent. Thus, mtDNA
deletions are not responsible for the pro-
geroid syndrome of homozygous mutator
mice.
Wewould like to point out that the insta-
bility of the supercomplexes is an inter-
esting feature of the mutator mice, but
Edgar et al. provide no experiments to
show that this instability is indeed causal
to their progeroid syndrome. Thus, it
seems incorrect to argue that mtDNA
deletions are not important for the pheno-
type of the mice because they have no
role in supercomplex instability.
Second, the assays used to quantify
mtDNA deletions and, thus, discard them
as irrelevant are inappropriate for their
detection. Previously, we demonstrated
that mtDNA deletions in the mutator
mice are generated randomly. As a result,
the majority of deleted molecules are
unique and of a different size. Although
these molecules may clonally expand
within single cells, this variability pre-
cludes their detection on a Southern blot,
since no single-sized molecule predomi-
nates. Furthermore, random deletions
are unlikely to be detected with the PCR
assay used. To illustrate, if a thousand
molecules are present in a PCR reaction
and one hundred of these carry an iden-
tical deletion, this deletion is easily de-
tected. However, if the size of each dele-
tion is different, the signal of any deleted
molecule will be too faint to detect.
Importantly, the control experiments that
demonstrate a 0.1% sensitivity of detec-
tion are done on clonally expanded
mtDNA deletions and are thus inappro-
priate for the detection of random dele-
tions. Similarly, due to their uneven distri-
bution and location, it is also not expected
that these deletions will cause a drop in
protein levels, especially when a large
group of cells is assayed simultaneously,
and the signal of each individual cell is
averaged out.Cell Metabolism 10Finally, in human pathology, low num-
bers of deletions are thought to contribute
significantly to muscle wasting and neu-
ronal degradation. Thus, a low level of
mtDNAdeletions inmitochondrial mutator
mice does not preclude an impact on
animal physiology. If the hypothesis by
Edgar et al. holds true though and point
mutations are the sole cause of their pro-
geroid syndrome, the mutator mice can
no longer be regarded as an accurate
model for normal aging, as point muta-
tions do not cause aging in wild-type
mice (Vermulst et al., 2007). Moreover, if
a 10- to 90-fold increase in deletions is
negligible in terms of pathology, this
partially conflicts with the mitochondrial
theory of aging. However, we conclude
that the methodology used by Edgar
et al. is insufficient to resolve this contro-
versy (Kraytsberg et al., 2009).
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